Frontlight ResearchEarly access
CompletedNo phase
CGM in Patients With ED's
Key facts
- Who runs it
- Denver Health and Hospital Authority
- Where
- Denver, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 50 people enrolled
- Started
- 9 May 2023
- Ended
- 2 Jul 2024
- Type of study
- Observational
- Treatments tested
- Continuous Glucose Monitor
- Record updated
- 5 February 2025
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Ages 18-65 and meet the DSM-V criteria for AN-R or AN-BP or ARFID
- Admission %IBW ≤ 75%
Who cannot take part
- Diagnosed with an eating disorder other than AN-R or AN-BP or ARFID
- %IBW > 75% on admission
- Inability to give informed consent to participate/lacks decisional capacity
- Unable to follow the study protocol
- Transferred to the unit on a mental health hold/short term certification
- Treatment team refusal of patient's participation
Where in United States
- Denver Health and Hospital AuthorityDenver, United States
About the trial
What the trial wants to find out
To determine the accuracy of continuous glucose monitoring (CGM) with point of care (POC) fingerstick glucose monitoring and venous blood glucose in patients with eating disorders, specifically anorexia nervosa, restricting subtype (AN-R); avoidant/restrictive food intake disorder (ARFID); and anorexia nervosa, binge/purge subtype (AN-BP).
The group in the trial
- CGM
Treatment: Continuous Glucose Monitor
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Glucose Monitoring in Patients With Eating Disorders: A Pilot Study
- Record updated
- 5 February 2025